Biotech

All Articles

Sanofi fails MS study, giving another strike to Denali contract

.Sanofi has actually stopped a stage 2 hardship of Denali Therapeutics-partnered oditrasertib in sev...

Turnstone lays off 60%, agitates C-suite to extend cash

.Turnstone Biologics is lessening its headcount through 60% as well as shaking up its own C-suite to...

Gilead gives up on $15M MASH bet after weighing preclinical records

.In a year that has actually viewed an approval and a plethora of readouts for metabolic dysfunction...

Texas biotech axes cancer treaty, pins wishes on being overweight

.Alaunos Rehabs is actually axing a contract with Precigen, giving up licensing rights to a tailored...

Capricor allotments more data for DMD therapy after initiating BLA

.Capricor Rehabs is actually taking a success tour for their stage 2 Duchenne muscle dystrophy (DMD)...

FDA places Kezar lupus trial in grip complying with 4 person deaths

.The FDA has positioned Kezar Life Sciences' lupus trial on grip after the biotech hailed 4 fataliti...

Phase 3 Intellectual Rock test hits SMA goal, sending out stock up 200%

.A stage 3 trial of Intellectual Rock's spinal muscle degeneration (SMA) candidate has hit its own m...

CAMP 4 is most up-to-date to eye IPO, while Upstream point out $182M planning

.RNA biotech CAMP4 Therapies has actually defined think about a $67 million IPO, along with inflamma...

Galecto gets leukemia drug, falls bone cancer cells possession in pivot

.A year after the failing of an idiopathic lung fibrosis applicant sent Galecto on a look for redemp...

Judo throws down $100M to knock out renal health condition

.Taking the floor covering is Judo Bio, a promising biotech armed with $100 thousand to develop olig...